DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients-Reference-Cited by-同舟云学术

DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients

Published:2018-09 Issue:3 Volume:94 Page:589-598
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Karaboyas Angelo,Xu Hairong,Morgenstern Hal,Locatelli Francesco,Jadoul Michel,Nitta Kosaku,Dasgupta Indranil,Tentori Francesca,Port Friedrich K.,Robinson Bruce M.

Publisher

Elsevier BV

Subject

Nephrology

Reference46 articles.

1. Drugs targeting the renin-angiotensin-aldosterone system;Zaman;Nat Rev Drug Discov,2002

2. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal trial in myocardial infarction with angiotensin II antagonist losartan;Dickstein;Lancet,2002

3. A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly;Wing;N Engl J Med,2003

4. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis;Healey;J Am Coll Cardiol,2005

5. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease;Mancini;J Am Coll Cardiol,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10‐Year Outcomes of the Q‐Cohort Study;Journal of the American Heart Association;2024-08-06

2. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path;Reviews in Cardiovascular Medicine;2024-06-25

3. The Hypertensive Hemodialysis Patient: Features and Quality of Life Domains—Pakistan Perspectives;Handbook of the Behavior and Psychology of Disease;2024

4. Framework of Guidelines for Management of CKD in Asia;Kidney International Reports;2023-12

5. Effect of renin–angiotensin system inhibitors on cardiovascular events in hemodialysis patients with hyperphosphatemia: A post hoc analysis of the LANDMARK trial;Therapeutic Apheresis and Dialysis;2023-11-03